Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1994 Aug;57(8):886–896. doi: 10.1136/jnnp.57.8.886

Motor neuron disease.

P N Leigh 1, K Ray-Chaudhuri 1
PMCID: PMC1073069  PMID: 8057109

Full text

PDF
886

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behnia M., Kelly J. J. Role of electromyography in amyotrophic lateral sclerosis. Muscle Nerve. 1991 Dec;14(12):1236–1241. doi: 10.1002/mus.880141217. [DOI] [PubMed] [Google Scholar]
  2. Benoit E., Escande D. Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflugers Arch. 1991 Dec;419(6):603–609. doi: 10.1007/BF00370302. [DOI] [PubMed] [Google Scholar]
  3. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994 Mar 3;330(9):585–591. doi: 10.1056/NEJM199403033300901. [DOI] [PubMed] [Google Scholar]
  4. Bradley W. G. Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies. Muscle Nerve. 1987 Jul-Aug;10(6):490–502. doi: 10.1002/mus.880100603. [DOI] [PubMed] [Google Scholar]
  5. Caroni P., Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J Cell Biol. 1990 Apr;110(4):1307–1317. doi: 10.1083/jcb.110.4.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chancellor A. M., Slattery J. M., Fraser H., Swingler R. J., Holloway S. M., Warlow C. P. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol. 1993 Jun;240(6):339–346. doi: 10.1007/BF00839964. [DOI] [PubMed] [Google Scholar]
  7. Chancellor A. M., Warlow C. P. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1106–1115. doi: 10.1136/jnnp.55.12.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chaudhry V., Corse A. M., Cornblath D. R., Kuncl R. W., Drachman D. B., Freimer M. L., Miller R. G., Griffin J. W. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol. 1993 Mar;33(3):237–242. doi: 10.1002/ana.410330303. [DOI] [PubMed] [Google Scholar]
  9. Cheshire W. P. Robert Boyle and a corpuscular model of tremor. Neurology. 1992 Feb;42(2):455–456. doi: 10.1212/wnl.42.2.455. [DOI] [PubMed] [Google Scholar]
  10. Crossner C. G. Salivary flow rate in children and adolescents. Swed Dent J. 1984;8(6):271–276. [PubMed] [Google Scholar]
  11. Dean G., Elian M. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales. J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):633–637. doi: 10.1136/jnnp.56.6.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dittrich F., Thoenen H., Sendtner M. Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat. Ann Neurol. 1994 Feb;35(2):151–163. doi: 10.1002/ana.410350206. [DOI] [PubMed] [Google Scholar]
  13. Doble A., Hubert J. P., Blanchard J. C. Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells. Neurosci Lett. 1992 Jun 22;140(2):251–254. doi: 10.1016/0304-3940(92)90114-m. [DOI] [PubMed] [Google Scholar]
  14. Drachman D. B., Chaudhry V., Cornblath D., Kuncl R. W., Pestronk A., Clawson L., Mellits E. D., Quaskey S., Quinn T., Calkins A. Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Ann Neurol. 1994 Feb;35(2):142–150. doi: 10.1002/ana.410350205. [DOI] [PubMed] [Google Scholar]
  15. Duncan M. W., Steele J. C., Kopin I. J., Markey S. P. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology. 1990 May;40(5):767–772. doi: 10.1212/wnl.40.5.767. [DOI] [PubMed] [Google Scholar]
  16. Elian M., Dean G. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland. Neuroepidemiology. 1992;11(4-6):236–243. doi: 10.1159/000110936. [DOI] [PubMed] [Google Scholar]
  17. Friedman D. P., Tartaglino L. M. Amyotrophic lateral sclerosis: hyperintensity of the corticospinal tracts on MR images of the spinal cord. AJR Am J Roentgenol. 1993 Mar;160(3):604–606. doi: 10.2214/ajr.160.3.8430564. [DOI] [PubMed] [Google Scholar]
  18. Goodin D. S., Rowley H. A., Olney R. K. Magnetic resonance imaging in amyotrophic lateral sclerosis. Ann Neurol. 1988 Apr;23(4):418–420. doi: 10.1002/ana.410230424. [DOI] [PubMed] [Google Scholar]
  19. Gunnarsson L. G., Dahlbom K., Strandman E. Motor neuron disease and dementia reported among 13 members of a single family. Acta Neurol Scand. 1991 Nov;84(5):429–433. doi: 10.1111/j.1600-0404.1991.tb04983.x. [DOI] [PubMed] [Google Scholar]
  20. HIRANO A., KURLAND L. T., KROOTH R. S., LESSELL S. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain. 1961 Dec;84:642–661. doi: 10.1093/brain/84.4.642. [DOI] [PubMed] [Google Scholar]
  21. Harding A. E., Thomas P. K., Baraitser M., Bradbury P. G., Morgan-Hughes J. A., Ponsford J. R. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry. 1982 Nov;45(11):1012–1019. doi: 10.1136/jnnp.45.11.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Howard R. S., Wiles C. M., Loh L. Respiratory complications and their management in motor neuron disease. Brain. 1989 Oct;112(Pt 5):1155–1170. doi: 10.1093/brain/112.5.1155. [DOI] [PubMed] [Google Scholar]
  23. Hudson A. J. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain. 1981 Jun;104(2):217–247. doi: 10.1093/brain/104.2.217. [DOI] [PubMed] [Google Scholar]
  24. Jamal G. A., Weir A. I., Hansen S., Ballantyne J. P. Sensory involvement in motor neuron disease: further evidence from automated thermal threshold determination. J Neurol Neurosurg Psychiatry. 1985 Sep;48(9):906–910. doi: 10.1136/jnnp.48.9.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jokelainen M. Amyotrophic lateral sclerosis in Finland. II: Clinical characteristics. Acta Neurol Scand. 1977 Sep;56(3):194–204. doi: 10.1111/j.1600-0404.1977.tb01425.x. [DOI] [PubMed] [Google Scholar]
  26. Kelly J. J., Jr, Thibodeau L., Andres P. L., Finison L. J. Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials. Muscle Nerve. 1990 Jun;13(6):471–479. doi: 10.1002/mus.880130602. [DOI] [PubMed] [Google Scholar]
  27. Kew J. J., Goldstein L. H., Leigh P. N., Abrahams S., Cosgrave N., Passingham R. E., Frackowiak R. S., Brooks D. J. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain. 1993 Dec;116(Pt 6):1399–1423. doi: 10.1093/brain/116.6.1399. [DOI] [PubMed] [Google Scholar]
  28. Kimura F., Smith R. G., Delbono O., Nyormoi O., Schneider T., Nastainczyk W., Hofmann F., Stefani E., Appel S. H. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. Ann Neurol. 1994 Feb;35(2):164–171. doi: 10.1002/ana.410350207. [DOI] [PubMed] [Google Scholar]
  29. LAMBERT E. H., MULDER D. W. Electromyographic studies in amyotrophic lateral sclerosis. Proc Staff Meet Mayo Clin. 1957 Aug 21;32(17):441–446. [PubMed] [Google Scholar]
  30. La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991 Jul 4;352(6330):77–79. doi: 10.1038/352077a0. [DOI] [PubMed] [Google Scholar]
  31. Li T. M., Alberman E., Swash M. Clinical features and associations of 560 cases of motor neuron disease. J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1043–1045. doi: 10.1136/jnnp.53.12.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lilienfeld D. E., Chan E., Ehland J., Godbold J., Landrigan P. J., Marsh G., Perl D. P. Rising mortality from motoneuron disease in the USA, 1962-84. Lancet. 1989 Apr 1;1(8640):710–713. doi: 10.1016/s0140-6736(89)92218-6. [DOI] [PubMed] [Google Scholar]
  33. Moss A. H., Casey P., Stocking C. B., Roos R. P., Brooks B. R., Siegler M. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology. 1993 Feb;43(2):438–443. doi: 10.1212/wnl.43.2.438. [DOI] [PubMed] [Google Scholar]
  34. Mulder D. W., Kurland L. T., Offord K. P., Beard C. M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology. 1986 Apr;36(4):511–517. doi: 10.1212/wnl.36.4.511. [DOI] [PubMed] [Google Scholar]
  35. Neary D., Snowden J. S., Mann D. M., Northen B., Goulding P. J., Macdermott N. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry. 1990 Jan;53(1):23–32. doi: 10.1136/jnnp.53.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Neilson S., Robinson I., Clifford Rose F., Hunter M. Rising mortality from motor neurone disease: an explanation. Acta Neurol Scand. 1993 Mar;87(3):184–191. doi: 10.1111/j.1600-0404.1993.tb04098.x. [DOI] [PubMed] [Google Scholar]
  37. Newrick P. G., Langton-Hewer R. Pain in motor neuron disease. J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):838–840. doi: 10.1136/jnnp.48.8.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Norris F. H., Smith R. A., Denys E. H. Motor neurone disease: towards better care. Br Med J (Clin Res Ed) 1985 Jul 27;291(6490):259–262. doi: 10.1136/bmj.291.6490.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Norris F., Shepherd R., Denys E., U K., Mukai E., Elias L., Holden D., Norris H. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993 Aug;118(1):48–55. doi: 10.1016/0022-510x(93)90245-t. [DOI] [PubMed] [Google Scholar]
  40. O'Brien T., Kelly M., Saunders C. Motor neurone disease: a hospice perspective. BMJ. 1992 Feb 22;304(6825):471–473. doi: 10.1136/bmj.304.6825.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Oba H., Araki T., Ohtomo K., Monzawa S., Uchiyama G., Koizumi K., Nogata Y., Kachi K., Shiozawa Z., Kobayashi M. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology. 1993 Dec;189(3):843–846. doi: 10.1148/radiology.189.3.8234713. [DOI] [PubMed] [Google Scholar]
  42. Olivares L., Estéban E. S., Alter M. Mexican "resistance" to amyotrophic lateral sclerosis. Arch Neurol. 1972 Nov;27(5):397–402. doi: 10.1001/archneur.1972.00490170029005. [DOI] [PubMed] [Google Scholar]
  43. Oppenheim R. W., Yin Q. W., Prevette D., Yan Q. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature. 1992 Dec 24;360(6406):755–757. doi: 10.1038/360755a0. [DOI] [PubMed] [Google Scholar]
  44. Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve. 1991 Oct;14(10):927–936. doi: 10.1002/mus.880141002. [DOI] [PubMed] [Google Scholar]
  45. Plaitakis A., Berl S., Yahr M. D. Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder. Science. 1982 Apr 9;216(4542):193–196. doi: 10.1126/science.6121377. [DOI] [PubMed] [Google Scholar]
  46. Pringle C. E., Hudson A. J., Munoz D. G., Kiernan J. A., Brown W. F., Ebers G. C. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain. 1992 Apr;115(Pt 2):495–520. doi: 10.1093/brain/115.2.495. [DOI] [PubMed] [Google Scholar]
  47. Rodgers-Johnson P., Garruto R. M., Yanagihara R., Chen K. M., Gajdusek D. C., Gibbs C. J., Jr Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathologic trends. Neurology. 1986 Jan;36(1):7–13. doi: 10.1212/wnl.36.1.7. [DOI] [PubMed] [Google Scholar]
  48. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 Mar 4;362(6415):59–62. doi: 10.1038/362059a0. [DOI] [PubMed] [Google Scholar]
  49. Rowland L. P. Amyotrophic lateral sclerosis: theories and therapies. Ann Neurol. 1994 Feb;35(2):129–130. doi: 10.1002/ana.410350202. [DOI] [PubMed] [Google Scholar]
  50. Sadiq S. A., Thomas F. P., Kilidireas K., Protopsaltis S., Hays A. P., Lee K. W., Romas S. N., Kumar N., van den Berg L., Santoro M. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 1990 Jul;40(7):1067–1072. doi: 10.1212/wnl.40.7.1067. [DOI] [PubMed] [Google Scholar]
  51. Sienko D. G., Davis J. P., Taylor J. A., Brooks B. R. Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol. 1990 Jan;47(1):38–41. doi: 10.1001/archneur.1990.00530010046017. [DOI] [PubMed] [Google Scholar]
  52. Smith R. G., Hamilton S., Hofmann F., Schneider T., Nastainczyk W., Birnbaumer L., Stefani E., Appel S. H. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med. 1992 Dec 10;327(24):1721–1728. doi: 10.1056/NEJM199212103272405. [DOI] [PubMed] [Google Scholar]
  53. Spencer P. S., Nunn P. B., Hugon J., Ludolph A. C., Ross S. M., Roy D. N., Robertson R. C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987 Jul 31;237(4814):517–522. doi: 10.1126/science.3603037. [DOI] [PubMed] [Google Scholar]
  54. Swash M., Leigh N. Criteria for diagnosis of familial amyotrophic lateral sclerosis. European FALS Collaborative Group. Neuromuscul Disord. 1992;2(1):7–9. doi: 10.1016/0960-8966(92)90020-7. [DOI] [PubMed] [Google Scholar]
  55. Swash M., Scholtz C. L., Vowles G., Ingram D. A. Selective and asymmetric vulnerability of corticospinal and spinocerebellar tracts in motor neuron disease. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):785–789. doi: 10.1136/jnnp.51.6.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Szabo A., Dalmau J., Manley G., Rosenfeld M., Wong E., Henson J., Posner J. B., Furneaux H. M. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell. 1991 Oct 18;67(2):325–333. doi: 10.1016/0092-8674(91)90184-z. [DOI] [PubMed] [Google Scholar]
  57. Tucker T., Layzer R. B., Miller R. G., Chad D. Subacute, reversible motor neuron disease. Neurology. 1991 Oct;41(10):1541–1544. doi: 10.1212/wnl.41.10.1541. [DOI] [PubMed] [Google Scholar]
  58. Veltema A. N., Roos R. A., Bruyn G. W. Autosomal dominant adult amyotrophic lateral sclerosis. A six generation Dutch family. J Neurol Sci. 1990 Jun;97(1):93–115. doi: 10.1016/0022-510x(90)90101-r. [DOI] [PubMed] [Google Scholar]
  59. Yan Q., Elliott J., Snider W. D. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature. 1992 Dec 24;360(6406):753–755. doi: 10.1038/360753a0. [DOI] [PubMed] [Google Scholar]
  60. Younger D. S., Rowland L. P., Latov N., Hays A. P., Lange D. J., Sherman W., Inghirami G., Pesce M. A., Knowles D. M., Powers J. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol. 1991 Jan;29(1):78–86. doi: 10.1002/ana.410290114. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES